The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

Focal-adhesion kinase (FAK) is an important mediator of growth-factor signalling, cell proliferation, cell survival and cell migration. Given that the development of malignancy is often associated with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells. Mouse models have shown that FAK is involved in tumour formation and progression, and other studies showing that FAK expression is increased in human tumours make FAK a potentially important new therapeutic target.

[1]  E. Ruoslahti,et al.  Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. , 2001, Cancer research.

[2]  W. Cance,et al.  Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.

[3]  V. Golubovskaya,et al.  Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. , 2003, Molecular cancer research : MCR.

[4]  V. Golubovskaya,et al.  Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[5]  S. Hanks,et al.  Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. , 2003, Frontiers in bioscience : a journal and virtual library.

[6]  S. Matsuda,et al.  A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. , 2002, Biochemical and biophysical research communications.

[7]  G. Gillespie,et al.  Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. , 2002, Cancer research.

[8]  S. Mizutani,et al.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. , 1998, Cancer research.

[9]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.

[10]  B. van de Water,et al.  Suppression of Chemically Induced Apoptosis but Not Necrosis of Renal Proximal Tubular Epithelial (LLC-PK1) Cells by Focal Adhesion Kinase (FAK) , 2001, The Journal of Biological Chemistry.

[11]  Selective GRB2 SH2 inhibitors as anti‐Ras therapy , 1999, International journal of cancer.

[12]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[13]  T. Argyris,et al.  Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice. , 1980, The Journal of investigative dermatology.

[14]  Sarah Glover,et al.  Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  B. van de Water,et al.  Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. , 2005, Cancer research.

[16]  Y. Lim,et al.  Phosphorylation of Focal Adhesion Kinase at Tyrosine 861 Is Crucial for Ras Transformation of Fibroblasts* , 2004, Journal of Biological Chemistry.

[17]  C. Livasy,et al.  Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  K. Wary,et al.  Transforming growth factor β regulates cell–cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells , 2004, Oncogene.

[19]  T. Tanita,et al.  Endothelial Barrier Strengthening by Activation of Focal Adhesion Kinase* , 2003, The Journal of Biological Chemistry.

[20]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  H. Kuwano,et al.  FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[22]  F. Lee,et al.  A role for Src-family kinases in imatinib resistant chronic myelogenous leukemia , 2005 .

[23]  M. Matter,et al.  Inhibition of pp125FAK in cultured fibroblasts results in apoptosis , 1996, The Journal of cell biology.

[24]  C. Potten,et al.  Caspase activation during spontaneous and radiation‐induced apoptosis in the murine intestine , 2001, The Journal of pathology.

[25]  F P Retief,et al.  [The first ten years]. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[26]  J. Parsons,et al.  Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.

[27]  L. Kornberg.  Focal adhesion kinase and its potential involvement in tumor invasion and metastasis , 1998, Head & neck.

[28]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[29]  C. Damsky,et al.  Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.

[30]  M. Tang,et al.  Suppression of Ultraviolet Irradiation-induced Apoptosis by Overexpression of Focal Adhesion Kinase in Madin-Darby Canine Kidney Cells* , 1999, The Journal of Biological Chemistry.

[31]  J. Sebolt-Leopold.  Development of anticancer drugs targeting the MAP kinase pathway , 2000, Oncogene.

[32]  B. Werness,et al.  Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18 , 1997, Oncogene.

[33]  S. Hanks,et al.  Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. , 1996, Biochemical and biophysical research communications.

[34]  M. Schwartz,et al.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.

[35]  T. Sawyer,et al.  Src inhibitors: genomics to therapeutics , 2001, Expert opinion on investigational drugs.

[36]  S. Hanks,et al.  Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor-Interacting Protein , 2004, Molecular and Cellular Biology.

[37]  P Chambon,et al.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. , 1999, Nucleic acids research.

[38]  Anil K Sood,et al.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. , 2004, The American journal of pathology.

[39]  D. Schlaepfer,et al.  FRNK blocks v‐Src‐stimulated invasion and experimental metastases without effects on cell motility or growth , 2002, The EMBO journal.

[40]  M. Frame,et al.  Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.

[41]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[42]  Xiaping He,et al.  Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma , 1999, Cancer.

[43]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[44]  A. Bresnick,et al.  Roles of Rho-associated Kinase and Myosin Light Chain Kinase in Morphological and Migratory Defects of Focal Adhesion Kinase-null Cells* , 2002, The Journal of Biological Chemistry.

[45]  J. Parsons,et al.  A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK , 1996, Nature.

[46]  M. Tatsuta,et al.  Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  D. Schlaepfer,et al.  Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.

[48]  L. Kornberg,et al.  Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx , 2003, The Laryngoscope.

[49]  T. Hunter,et al.  Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases , 1996, Molecular and cellular biology.

[50]  D. Sheppard,et al.  Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling , 2002, The Journal of cell biology.

[51]  E. Schaefer,et al.  Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies , 2001, Oncogene.

[52]  S. Weed,et al.  Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement , 2000, Oncogene.

[53]  Gerald R. Fink,et al.  Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex , 2002, Nature Cell Biology.

[54]  N. Carragher,et al.  Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. , 2004, Trends in cell biology.

[55]  C. Damsky,et al.  Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. , 2001, The American journal of pathology.

[56]  Q. Ding,et al.  Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  S. Grant,et al.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.

[58]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[59]  S. Hanks,et al.  Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells , 2004, Oncogene.

[60]  H.-W. Chung,et al.  The expression and tyrosine phosphorylation of E‐cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[61]  Z. Salah,et al.  Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples , 2005, International journal of cancer.

[62]  V. Golubovskaya,et al.  Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. , 2004, Biochimica et biophysica acta.

[63]  R. Bodnar,et al.  Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation , 2004, Molecular and Cellular Biology.

[64]  S. Hanks,et al.  Identification of p130Cas as a Mediator of Focal Adhesion Kinase–promoted Cell Migration , 1998, The Journal of cell biology.

[65]  A. Richardson,et al.  A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK , 1996, Nature.

[66]  Neil O. Carragher,et al.  A Novel Role for FAK as a Protease-Targeting Adaptor Protein Regulation by p42 ERK and Src , 2003, Current Biology.

[67]  A. Balmain,et al.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis , 1986, Nature.

[68]  S. Ashley,et al.  RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. , 2003, Biochemical and biophysical research communications.

[69]  G. Nemerow,et al.  Differential regulation of cell motility and invasion by FAK , 2003, The Journal of cell biology.

[70]  D. Schlaepfer,et al.  Control of motile and invasive cell phenotypes by focal adhesion kinase. , 2004, Biochimica et biophysica acta.

[71]  L. Kornberg,et al.  Focal adhesion kinase expression in oral cancers , 1998, Head & neck.

[72]  N. Carragher,et al.  Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling , 2004, Molecular and Cellular Biology.

[73]  S. Hanks,et al.  Anti-apoptotic Role of Focal Adhesion Kinase (FAK): Induction of Inhibitor-of-Apoptosis Proteins and Apoptosis Suppression by the Overexpression of FAK in a Human Leukemic Cell Line, HL-60 , 2000 .

[74]  J. Aguirre Ghiso.  Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[75]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[76]  S. Hanks,et al.  Roles played by a subset of integrin signaling molecules in cadherin-based cell–cell adhesion , 2004, The Journal of cell biology.

[77]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[78]  C. Damsky,et al.  Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. , 2000 .

[79]  I. Gelman,et al.  v-Src Rescues Actin-based Cytoskeletal Architecture and Cell Motility and Induces Enhanced Anchorage Independence during Oncogenic Transformation of Focal Adhesion Kinase-null Fibroblasts* , 2003, Journal of Biological Chemistry.

[80]  J. Ruidavets,et al.  Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. , 2004, Cancer research.

[81]  A. Karginov,et al.  The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. , 2002, Molecular biology of the cell.

[82]  Kenneth M. Yamada,et al.  Dimensions and dynamics in integrin function. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[83]  T. Takenawa,et al.  Focal Adhesion Kinase Regulation of N-WASP Subcellular Localization and Function* , 2004, Journal of Biological Chemistry.

[84]  G. McLean,et al.  Focal adhesion kinase as a potential target in oncology , 2003, Expert opinion on pharmacotherapy.

[85]  S. Franco,et al.  Isoform specific function of calpain 2 in regulating membrane protrusion. , 2004, Experimental cell research.

[86]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[87]  V. Golubovskaya,et al.  Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. , 2003, The Biochemical journal.

[88]  M. Schaller.  Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.

[89]  N. Carragher,et al.  Degraded Collagen Fragments Promote Rapid Disassembly of Smooth Muscle Focal Adhesions That Correlates with Cleavage of Pp125FAK, Paxillin, and Talin , 1999, The Journal of cell biology.

[90]  R. Schüle,et al.  Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. , 2004, Anticancer research.

[91]  S. Ashley,et al.  Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. , 2004, Surgery.

[92]  Donna J. Webb,et al.  FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly , 2004, Nature Cell Biology.

[93]  W. Cance,et al.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[94]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[95]  Ken Jacobson,et al.  JNK phosphorylates paxillin and regulates cell migration , 2003, Nature.

[96]  D. Schlaepfer,et al.  v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.

[97]  A. Merlo,et al.  PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). , 2001, Cancer research.

[98]  Kenneth M. Yamada,et al.  Targeting Membrane-localized Focal Adhesion Kinase to Focal Adhesions , 2003, Journal of Biological Chemistry.

[99]  C. Damsky,et al.  FAK promotes organization of fibronectin matrix and fibrillar adhesions , 2004, Journal of Cell Science.

[100]  Anna Huttenlocher,et al.  Calpain-mediated proteolysis of talin regulates adhesion dynamics , 2004, Nature Cell Biology.

[101]  J. Guan,et al.  Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. , 1996, Journal of cell science.

[102]  J. Taylor,et al.  An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase , 1996, Molecular and cellular biology.

[103]  Sean P. Palecek,et al.  Regulation of Cell Migration by the Calcium-dependent Protease Calpain* , 1997, The Journal of Biological Chemistry.

[104]  J. Gutkind,et al.  Regulation of G Protein-linked Guanine Nucleotide Exchange Factors for Rho, PDZ-RhoGEF, and LARG by Tyrosine Phosphorylation , 2002, The Journal of Biological Chemistry.

[105]  J. Ghiso.  Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[106]  D. Schlaepfer,et al.  Direct Interaction of Focal Adhesion Kinase with p190RhoGEF* , 2003, Journal of Biological Chemistry.

[107]  K. Hahn,et al.  Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility , 2004, The Journal of cell biology.

[108]  Ming Huang,et al.  Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. , 2002, World journal of gastroenterology.

[109]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[110]  A. Wells,et al.  DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. , 2004, Experimental cell research.

[111]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[112]  H. Hamada,et al.  Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G. , 2002, Biochemical and biophysical research communications.

[113]  C. Welter,et al.  Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological type , 1999, International journal of cancer.

[114]  S. Hanks,et al.  Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.

[115]  E. Avizienyte,et al.  Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. , 2005, Cancer research.

[116]  E. Avizienyte,et al.  Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. , 2004, Molecular biology of the cell.

[117]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[118]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[119]  N. Carragher,et al.  Cleavage of Focal Adhesion Kinase by Different Proteases during Src-regulated Transformation and Apoptosis , 2001, The Journal of Biological Chemistry.

[120]  W. Cance,et al.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.

[121]  Tony Hunter,et al.  Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.

[122]  E. Blomme,et al.  Comparison of immunohistochemistry for activated caspase‐3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC‐3 subcutaneous xenografts , 2003, The Journal of pathology.

[123]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[124]  M. Tang,et al.  Tyrosine Phosphorylation of Focal Adhesion Kinase Stimulated by Hepatocyte Growth Factor Leads to Mitogen-activated Protein Kinase Activation* , 1998, The Journal of Biological Chemistry.

[125]  G. McLean,et al.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling , 2002, Nature Cell Biology.

[126]  P. Friedl.  Prespecification and plasticity: shifting mechanisms of cell migration. , 2004, Current opinion in cell biology.